Featured Image

18.07.2021 | Published by Business Weekly

£200m+ invested in Babraham Campus companies, what lies ahead?

Derek Jones, Chief Executive of the Babraham Research Campus

On Wednesday 14 July 2021, bit.bio attended The Babraham Investor Conference 2021 (BIC), an event for investors focusing on early-stage and scale-up life science and med-tech companies. bit.bio Co-Founder Florian Schuster was the second scale-up speaker.

Derek Jones, Chief Executive of the Babraham Research Campus opened the event by outlining how the Campus directly impacts the investor community: “Research has shown that investors see a 7.2 x return on investments on average in Campus companies.”

Florian revealed how bit.bio is coding human cells for health, to precision engineer the next generation of medicine.

Florian Schuster Co-Founder, CFO and COO bit.bio said:

“We are solving the manufacturing problem of human cells which allows us to overcome the major problems our sector is currently facing: the reproducibility issues in scientific research, the translational gap in drug development, and to make cell therapies consistent and scalable.”

 

Florian Schuster v2


Florian Schuster
Co-Founder, CFO and COO
bit.bio

 

bit.bio has raised more than £50 million in seed and Series A funding.

Full article access

Related pages

About us Coding cells to advance the wellbeing of humanity
Careers See the latest openings
Blog See the latest blogs